Eunice L. Kwak
- Oncology top 0.1%
- Pancreatic and Hepatic Oncology Research 38
- Colorectal Cancer Treatments and Studies 31
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics 23
- Pulmonary and Respiratory Medicine top 0.2%
- Gastric Cancer Management and Outcomes 24
- Lung Cancer Treatments and Mutations 22
- Hepatology top 1%
- Pathology and Forensic Medicine top 0.5%
-
- PI3K/AKT/mTOR signaling in cancer 14
-
- Neuroendocrine Tumor Research Advances 12
-
- Cholangiocarcinoma and Gallbladder Cancer Studies 10
- Co-authors
- Daniel A. HaberSubba R. DigumarthyJeffrey W. ClarkDaphne W. BellAlona MuzikanskyA. John IafrateDavid P. RyanLecia V. Sequist
- Journals
- Nature (1 paper)New England Journal of Medicine (3 papers)Proceedings of the National Academy of Sciences (1 paper)
- Partner nations
- United StatesSouth KoreaUnited Kingdom
In The Last Decade
Eunice L. Kwak
129 papers receiving 12.3k citations
Hit Papers
Peers
Comparison fields: 5 of 142
- Oncology 7.1k
- Cancer Research 2.8k
- Pulmonary and Respiratory Medicine 5.3k
- Hepatology 625
- Pathology and Forensic Medicine 1.3k
Countries citing papers authored by Eunice L. Kwak
This map shows the geographic impact of Eunice L. Kwak's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eunice L. Kwak with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eunice L. Kwak more than expected).
Fields of papers citing papers by Eunice L. Kwak
This network shows the impact of papers produced by Eunice L. Kwak. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eunice L. Kwak. The network helps show where Eunice L. Kwak may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Eunice L. Kwak, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2023 | 1 | |
| 2 | 2018 | 42 | |
| 3 | 2017 | 76 | |
| 4 | 2017 | 39 | |
| 5 | 2016 | 17 | |
| 6 | 2015 | 97 | |
| 7 | 2015 | 138 | |
| 8 | 2015 | 17 | |
| 9 | 2015 | 42 | |
| 10 | 2014 | 75 | |
| 11 | 2013 | 38 | |
| 12 | 2013 | 123 | |
| 13 | 2013 | 5 | |
| 14 | 2012 | 324 | |
| 15 | 2010 | 57 | |
| 16 | 2010 | 62 | |
| 17 | Crizotinib inALK-Rearranged Inflammatory Myofibroblastic Tumorbreakdown → | 2010 | 604 |
| 18 | Clinical Features and Outcome of Patients With Non–Small-Cell Lung Cancer Who Harbor EML4-ALKbreakdown → | 2009 | 1463 |
| 19 | 2006 | 32 | |
| 20 | Irreversible inhibitors of the EGF receptor may circumvent acquired resistance to gefitinibbreakdown → | 2005 | 774 |
About Eunice L. Kwak
Eunice L. Kwak is a scholar working on Oncology, Cancer Research and Pulmonary and Respiratory Medicine, having authored 132 papers that have together received 12.6k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (38 papers), Colorectal Cancer Treatments and Studies (31 papers), Gastric Cancer Management and Outcomes (24 papers), Cancer Genomics and Diagnostics (23 papers), Lung Cancer Treatments and Mutations (22 papers), PI3K/AKT/mTOR signaling in cancer (14 papers), Neuroendocrine Tumor Research Advances (12 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). The work is most often cited by research in Oncology (7.1k citations), Cancer Research (2.8k citations) and Pulmonary and Respiratory Medicine (5.3k citations). Eunice L. Kwak has collaborated with scholars based in United States, South Korea and United Kingdom. Frequent co-authors include Daniel A. Haber, Subba R. Digumarthy, Jeffrey W. Clark, Daphne W. Bell, Alona Muzikansky, A. John Iafrate, David P. Ryan, Lecia V. Sequist, Mehmet Toner and Sunitha Nagrath. Their work appears in journals such as Nature, New England Journal of Medicine and Proceedings of the National Academy of Sciences.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.